Targeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance

dc.contributor.authorPrieto Durán, Alejandro
dc.contributor.authorMiró Martí, Ma. Lluïsa
dc.contributor.authorMargolles, Yago
dc.contributor.authorBernabeu Lorenzo, Manuel
dc.contributor.authorSalguero, David
dc.contributor.authorMerino Montero, Susana
dc.contributor.authorTomàs Magaña, Juan
dc.contributor.authorCorbera, Juan Alberto
dc.contributor.authorPérez Bosque, Anna
dc.contributor.authorHüttener Queiroz, Mário
dc.contributor.authorFernández, Luis Ángel
dc.contributor.authorJuárez Giménez, Antonio
dc.date.accessioned2025-07-17T11:56:19Z
dc.date.available2025-07-17T11:56:19Z
dc.date.issued2024-07-24
dc.date.updated2025-07-17T11:56:19Z
dc.description.abstractAntimicrobial resistance (AMR) poses a significant threat to human health. Although vaccines have been developed to combat AMR, it has proven challenging to associate specific vaccine antigens with AMR. Bacterial plasmids play a crucial role in the transmission of AMR. Our recent research has identified a group of bacterial plasmids (specifically, IncHI plasmids) that encode large molecular mass proteins containing bacterial immunoglobulin-like domains. These proteins are found on the external surface of the bacterial cells, such as in the flagella or conjugative pili. In this study, we show that these proteins are antigenic and can protect mice from infection caused by an AMR Salmonella strain harboring one of these plasmids. Furthermore, we successfully generated nanobodies targeting these proteins, that were shown to interfere with the conjugative transfer of IncHI plasmids. Considering that these proteins are also encoded in other groups of plasmids, such as IncA/C and IncP2, targeting them could be a valuable strategy in combating AMR infections caused by bacteria harboring different groups of AMR plasmids. Since the selected antigens are directly linked to AMR itself, the protective effect extends beyond specific microorganisms to include all those carrying the corresponding resistance plasmids.
dc.format.extent23 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec753932
dc.identifier.issn2050-084X
dc.identifier.urihttps://hdl.handle.net/2445/222338
dc.language.isoeng
dc.publishereLife Sciences
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.7554/eLife.95328.3
dc.relation.ispartofeLife, 2024, vol. 13, p. 1-23
dc.relation.urihttps://doi.org/10.7554/eLife.95328.3
dc.rightscc-by (c) Prieto, A. et al., 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject.classificationMicrobiologia
dc.subject.classificationSalmonel·la
dc.subject.classificationMalalties infeccioses
dc.subject.otherMicrobiology
dc.subject.otherSalmonella
dc.subject.otherCommunicable diseases
dc.titleTargeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
877589.pdf
Mida:
5.97 MB
Format:
Adobe Portable Document Format

Paquet de llicències

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
license.txt
Mida:
1.71 KB
Format:
Item-specific license agreed upon to submission
Descripció: